- Home
- MURA vs TORO Comparison
MURA vs TORO Comparison
Compare MURA & TORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MURA
- TORO
- Stock Information
- Founded
- MURA 2013
- TORO 2022
- Country
- MURA Ireland
- TORO Cyprus
- Employees
- MURA N/A
- TORO N/A
- Industry
- MURA
- TORO Marine Transportation
- Sector
- MURA
- TORO Consumer Discretionary
- Exchange
- MURA Nasdaq
- TORO Nasdaq
- Market Cap
- MURA 45.8M
- TORO 36.7M
- IPO Year
- MURA N/A
- TORO N/A
- Fundamental
- Price
- MURA $2.46
- TORO $2.25
- Analyst Decision
- MURA Strong Buy
- TORO
- Analyst Count
- MURA 4
- TORO 0
- Target Price
- MURA $13.00
- TORO N/A
- AVG Volume (30 Days)
- MURA 106.6K
- TORO 435.6K
- Earning Date
- MURA 08-12-2025
- TORO 08-11-2025
- Dividend Yield
- MURA N/A
- TORO N/A
- EPS Growth
- MURA N/A
- TORO N/A
- EPS
- MURA N/A
- TORO 1.09
- Revenue
- MURA N/A
- TORO $22,394,283.00
- Revenue This Year
- MURA N/A
- TORO N/A
- Revenue Next Year
- MURA N/A
- TORO N/A
- P/E Ratio
- MURA N/A
- TORO $2.09
- Revenue Growth
- MURA N/A
- TORO 0.40
- 52 Week Low
- MURA $0.95
- TORO $1.70
- 52 Week High
- MURA $4.74
- TORO $4.08
- Technical
- Relative Strength Index (RSI)
- MURA 44.84
- TORO 57.21
- Support Level
- MURA $2.51
- TORO $2.10
- Resistance Level
- MURA $2.66
- TORO $2.52
- Average True Range (ATR)
- MURA 0.09
- TORO 0.18
- MACD
- MURA -0.02
- TORO 0.04
- Stochastic Oscillator
- MURA 20.08
- TORO 60.76
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.